Avita Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.8k | 544 | 5.11 |
| 2025-06-30 | $80k | 15k | 5.29 |
| 2025-03-31 | $160k | 20k | 8.14 |
| 2024-12-31 | $292k | 23k | 12.80 |
| 2024-09-30 | $137k | 13k | 10.72 |
| 2024-06-30 | $100k | 13k | 7.92 |
| 2024-03-31 | $245k | 15k | 16.03 |
| 2023-12-31 | $221k | 16k | 13.72 |
| 2023-09-30 | $227k | 16k | 14.61 |
| 2023-06-30 | $193k | 11k | 17.01 |
| 2022-03-31 | $120k | 14k | 8.47 |
| 2021-12-31 | $183k | 16k | 11.65 |
| 2021-09-30 | $269k | 15k | 18.01 |
| 2021-06-30 | $304k | 15k | 20.13 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft